• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.37% Nasdaq Up0.34%

    ACADIA Pharmaceuticals Inc. (ACAD)

    -NasdaqGS
    41.45 Down 0.10(0.24%) 10:09AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 4   48   14   28  
    Cost of Revenue -   -   -   -  
    Gross Profit 4   48   14   28  
    Operating Expenses
    Research Development16,295  18,182  16,953  13,799  
    Selling General and Administrative24,261  10,420  8,056  7,952  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (40,552) (28,554) (24,995) (21,723)
    Income from Continuing Operations
    Total Other Income/Expenses Net177  188  209  228  
    Earnings Before Interest And Taxes(40,375)(28,366)(24,786)(21,495)
    Interest Expense -   -   -   -  
    Income Before Tax(40,375)(28,366)(24,786)(21,495)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(40,375)(28,366)(24,786)(21,495)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (40,375) (28,366) (24,786) (21,495)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (40,375) (28,366) (24,786) (21,495)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.